13F Holdings
中文EN

BFRG BullFrog AI Holdings, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1829247 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY4.1%
TTM EPS YoY40.6%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-184.0%
ROA-152.0%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets12.4%
Debt / equity0.00x
Current ratio7.75x
Interest coverage-1,202.80x

Cash quality & payout

Operating cash flow / net income0.97x
Accruals ratio-4.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$116,670—$65,000$10,000—
Cost of revenue$94,778—$5,200$800—
Gross profit$21,892—$59,800$9,200—
R&D expense$1.80M$2.22M$1.43M$609,270$25,000
SG&A expense$4.82M$5.01M$3.99M$1.86M$327,329
Operating income-$6.59M-$7.24M-$5.37M-$2.46M-$555,362
Interest expense$5,629$18,158$79,089$347,145$40,395
Net income-$6.50M-$6.99M-$5.36M-$2.80M-$585,840
EBITDA-$6.59M-$7.23M-$5.37M-$2.45M—
EPS (basic)-0.63-0.85-0.89-0.70-14.00
EPS (diluted)-0.63-0.85-0.89-0.70—
Weighted avg. shares (diluted)10.34M8.25M6.05M4.01M—
Balance sheet
Cash & equivalents$2.18M$5.44M$2.62M$57,670$10,014
Receivables$0————
Current assets$2.58M$5.55M$2.77M$72,670$10,014
PP&E, net$2,525$4,250$5,974$7,699—
Total assets$2.81M$5.55M$2.78M$80,369$10,014
Current liabilities$672,022$588,090$184,350$3.14M$1.02M
Short-term debt————$49,000
Total liabilities$672,022$588,090$184,350$3.14M$1.02M
Shareholders' equity$2.14M$4.96M$2.59M-$3.06M-$1.01M
Shares outstanding11.42M9.11M6.09M4.02M4.62M
Cash flow statement
Operating cash flow-$5.52M-$5.61M-$6.00M-$910,890-$382,405
Capital expenditure———$8,744—
Free cash flow———-$919,634—
Investing cash flow———-$8,744—
Financing cash flow$2.37M$8.42M$8.57M$967,290$387,400
Depreciation & amortization$1,725$1,724$1,725$1,045—
Stock-based compensation$1.01M$943,649$631,533$340,152$98,951

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.